Stocks and Investing Stocks and Investing
Tue, June 4, 2019
Mon, June 3, 2019

Liana Moussatos Maintained (ASND) at Buy with Increased Target to $223 on, Jun 3rd, 2019


Published on 2024-10-26 14:01:25 - WOPRAI, Liana Moussatos
  Print publication without navigation


Liana Moussatos of Wedbush, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $219 to $223 on, Jun 3rd, 2019.

Liana has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Liana's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Liana


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $144 on, Friday, May 31st, 2019
  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $139 on, Friday, March 29th, 2019
Contributing Sources